Literature DB >> 15956700

Role of relaxin in maternal renal vasodilation of pregnancy.

Kirk P Conrad1, Arun Jeyabalan, Leslie A Danielson, Laurie J Kerchner, Jacqueline Novak.   

Abstract

The remarkable hemodynamic changes of normal pregnancy are briefly reviewed. In addition, new findings and current concepts related to the underlying hormonal and molecular mechanisms are presented. Finally, work that is in progress as well as future directions is briefly discussed.

Mesh：

Substances：

Year:  2005        PMID： 15956700     DOI： 10.1196/annals.1282.022

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


  5 in total

1.  Aspects to Consider in Adopting Pregnancy-Specific Reference Intervals.

Authors:  Narelle Hadlow; Ken Sikaris
Journal:  Clin Biochem Rev       Date:  2015-11

Review 2.  Glomerular hyperfiltration: definitions, mechanisms and clinical implications.

Authors:  Imed Helal; Godela M Fick-Brosnahan; Berenice Reed-Gitomer; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

3.  Chronic Nicotine Exposure Abolishes Maternal Systemic and Renal Adaptations to Pregnancy in Rats.

Authors:  Vanessa Meira Ferreira; Clevia Santos Passos; Edgar Maquigussa; Roberto Braz Pontes; Cassia Toledo Bergamaschi; Ruy Ribeiro Campos; Mirian Aparecida Boim
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

4.  Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.

Authors:  Giuseppe Penno; Emanuela Orsi; Anna Solini; Enzo Bonora; Cecilia Fondelli; Roberto Trevisan; Monica Vedovato; Franco Cavalot; Gabriella Gruden; Luigi Laviola; Antonio Nicolucci; Giuseppe Pugliese
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07

5.  Receptor-induced dilatation in the systemic and intrarenal adaptation to pregnancy in rats.

Authors:  Vanessa M Ferreira; Thiago S Gomes; Luciana A Reis; Alice T Ferreira; Clara V Razvickas; Nestor Schor; Mirian A Boim
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.